健康技术评估中审查类型选择指南:决定何时进行全新系统评价、系统评价更新或系统评价概述的关键因素和考虑因素。
Guidance on review type selection for health technology assessments: key factors and considerations for deciding when to conduct a de novo systematic review, an update of a systematic review, or an overview of systematic reviews.
机构信息
Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada.
Institute of Health Economics, Edmonton, AB, Canada.
出版信息
Syst Rev. 2022 Sep 27;11(1):206. doi: 10.1186/s13643-022-02071-7.
BACKGROUND
A systematic review (SR) helps us make sense of a body of research while minimizing bias and is routinely conducted to evaluate intervention effects in a health technology assessment (HTA). In addition to the traditional de novo SR, which combines the results of multiple primary studies, there are alternative review types that use systematic methods and leverage existing SRs, namely updates of SRs and overviews of SRs. This paper shares guidance that can be used to select the most appropriate review type to conduct when evaluating intervention effects in an HTA, with a goal to leverage existing SRs and reduce research waste where possible.
PROCESS
We identified key factors and considerations that can inform the process of deciding to conduct one review type over the others to answer a research question and organized them into guidance comprising a summary and a corresponding flowchart. This work consisted of three steps. First, a guidance document was drafted by methodologists from two Canadian HTA agencies based on their experience. Next, the draft guidance was supplemented with a literature review. Lastly, broader feedback from HTA researchers across Canada was sought and incorporated into the final guidance.
INSIGHTS
Nine key factors and six considerations were identified to help reviewers select the most appropriate review type to conduct. These fell into one of two categories: the evidentiary needs of the planned review (i.e., to understand the scope, objective, and analytic approach required for the review) and the state of the existing literature (i.e., to know the available literature in terms of its relevance, quality, comprehensiveness, currency, and findings). The accompanying flowchart, which can be used as a decision tool, demonstrates the interdependency between many of the key factors and considerations and aims to balance the potential benefits and challenges of leveraging existing SRs instead of primary study reports.
CONCLUSIONS
Selecting the most appropriate review type to conduct when evaluating intervention effects in an HTA requires a myriad of factors to be considered. We hope this guidance adds clarity to the many competing considerations when deciding which review type to conduct and facilitates that decision-making process.
背景
系统评价(SR)有助于我们理解研究文献,同时最大限度地减少偏倚,并且通常用于评估卫生技术评估(HTA)中的干预效果。除了将多个原始研究结果相结合的传统从头开始的 SR 之外,还有其他替代的审查类型,这些类型使用系统方法并利用现有的 SR,即 SR 更新和 SR 概述。本文提供了一些指导,可用于在 HTA 中评估干预效果时选择最合适的审查类型,目的是尽可能利用现有的 SR 并减少研究浪费。
过程
我们确定了关键因素和考虑因素,可以为决定选择一种审查类型而不是其他类型来回答研究问题提供信息,并将它们组织成指导文件,包括摘要和相应的流程图。这项工作包括三个步骤。首先,由来自两个加拿大 HTA 机构的方法学家根据他们的经验起草了一份指导文件。其次,该草案指导文件补充了文献综述。最后,征求了加拿大 HTA 研究人员的更广泛反馈意见,并将其纳入最终指导文件。
见解
确定了九个关键因素和六个考虑因素,以帮助审查员选择最合适的审查类型。这些因素分为两类:计划审查的证据需求(即,了解审查所需的范围、目标和分析方法)和现有文献的状况(即,了解现有文献的相关性、质量、全面性、时效性和研究结果)。所附的流程图可用作决策工具,展示了许多关键因素和考虑因素之间的相互依存关系,并旨在平衡利用现有 SR 而不是原始研究报告的潜在好处和挑战。
结论
在 HTA 中评估干预效果时,选择最合适的审查类型需要考虑许多因素。我们希望本指南能为决定进行哪种审查类型提供更多的考虑因素,并有助于决策过程。